Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples